SCHEMBL29795285

SCHEMBL29795285

CC(C)(C)OC(=O)N1CC2(C1)CN(c1cccc(N)c1N)C2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.43
SMARCA2 P51531 1/20 0.42
SMARCA4 P51532 1/20 0.42
PBRM1 Q86U86 1/20 0.42
GPR119 Q8TDV5 4/20 0.40
HDAC2 Q92769 2/20 0.39
HDAC1 Q13547 1/20 0.39
EGLN2 Q96KS0 1/20 0.39
GPR183 P32249 1/20 0.39
NR1H2 P55055 1/20 0.38
USP30 Q70CQ3 1/20 0.38
BCHE P06276 1/20 0.38
KDM1A O60341 2/20 0.38
SCD5 Q86SK9 1/20 0.38
PARP1 P09874 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
OXTR P30559 1/20 0.37
AVPR1A P37288 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123641 1.00 CYP11B2 (0.43) CYP11B2SMARCA2SMARCA4PBRM1GPR119
SCHEMBL31152780 0.85 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1GPR119
SCHEMBL1249642 0.85 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1GPR119
SCHEMBL23123008 0.85 ALDH1A1 (0.43) CYP11B2SMARCA2SMARCA4PBRM1GPR119
SCHEMBL30579527 0.81 DRD2 (0.47) CYP11B2OXTRAVPR1A
SCHEMBL23124336 0.81 HDAC1 (0.46) SMARCA2SMARCA4PBRM1GPR119HDAC2
SCHEMBL29795670 0.81 HDAC1 (0.46) SMARCA2SMARCA4PBRM1GPR119HDAC2
SCHEMBL14206383 0.81 CYP11B2 (0.55) CYP11B2SMARCA2SMARCA4PBRM1GPR119
SCHEMBL21358377 0.80 CYP11B2 (0.42) CYP11B2GPR119EGLN2GPR183BCHE
SCHEMBL29519767 0.80 CYP11B2 (0.42) CYP11B2GPR119EGLN2GPR183BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031532-A1 SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed